Research
Resources for Researchers
Research in NIAID Labs
Division of Intramural Research Labs
Research at Vaccine Research Center
Intramural Scientist & Clinician Directory
Research Rules & Policies
Clinical Research
Contracts
Grants & Funding
NIAID Role in Research
Accomplishments
HIV/AIDS
Infectious Diseases
Allergy, Immunology & Transplantation
Research in NIAID Labs
Research Funded by NIAID
Resources for Researchers
Programs & Networks
Partnerships
Research Areas
Antimicrobial (Drug) Resistance
Antimicrobial Resistance Threats
Research Initiatives
Basic Research
Causes
Prevention
Diagnosis
Treatment
Information for Researchers
Asthma
Risk Factors & Prevention Research
Managing Symptoms
Understanding Triggers
Autoimmune Diseases
Immune Tolerance Processes
Risk Factors
Treatment and Management
Disease-Specific Research
Information for Researchers
Autoimmune Lymphoproliferative Syndrome (ALPS)
Causes
Symptoms & Diagnosis
Treatment
Biodefense
Biodefense & Emerging Infectious Diseases
Chemical Countermeasures Research Program
Radiation & Nuclear Countermeasures Program
Cholera
Biology & Genetics
Treatment & Prevention
Coronaviruses
Basic & Preclinical Research
Vaccines & Prevention
Diagnostics & Serology
Treatment
Long COVID and MIS-C
Strategic Planning
Information for Researchers
Dengue Fever
Biology & Transmission
Prevention
Diagnosis
Treatment
Information for Researchers
E. coli
Shiga Toxin-Producing E. coli (STEC)
Prevention
Treatment
Ebola and Marburg
Vaccines
Diagnosis
Treatment
Researching Ebola in Africa
Information for Researchers
Eczema
Causes & Triggers
Prevention
Treatment聽
Complications
Information for Researchers
Food Allergy
Why Food Allergy is a Priority for NIAID
Causes & Prevention
Risk Factors
Diagnosis
Treatment
Characterizing Food Allergy & Addressing Related Disorders
Information for Researchers
Diagnosis & Management Guidelines
Fungal Diseases
Disease-Specific Research
Information for Researchers
Genomics & Advanced Technologies
Pathogen-Based Initiatives
Information for Researchers
Global Research
NIAID's Role
Regions
Information for Researchers
Group A Streptococcal Infections
Types of Group A Strep
Biology & Genetics
Vaccine Research
Hepatitis
Disease-Specific Research
HIV/AIDS
Prevention
Vaccine Development
Treatment
Cure
Information for Researchers
Immune System Research
Overview of the Immune System
Features of an Immune Response
Immune Cells
Immune Tolerance
Disorders
Research Frontiers
Information for Researchers
Influenza
Basic Research
Diagnosis
Treatment
Vaccines
Information for Researchers
Leishmaniasis
Parasite & Vector
Leprosy (Hansen's Disease)
Basic Research
Transmission
Research Next Steps
Lyme Disease
How NIAID is Addressing Lyme Disease
Diagnostics
Antibiotic Treatment
Chronic Lyme Disease
Co-Infection
Vaccines
Information for Researchers
Malaria
Parasite, Mosquito & Human Host
Prevention, Treatment & Control Strategies
Strategic Partnerships & Research Capacity
Information for Researchers
Mpox
Treatment
Vaccines
Information for Researchers
Neglected Tropical Diseases
NIAID's Role
Types of NTDs
Quick Facts
Scientific Findings
Information for Researchers
Pandemic Preparedness
Research Approach
Preclinical Research
Translational & Clinical Research
Cross-cutting Preparedness
Pertussis
Vaccines
Molecular & Genetic Research
Plague
Biology & Genetics
Primary Immune Deficiency Diseases (PIDDs)
Types of PIDDs
Genetics & Inheritance
Talking to Your Doctor
Information for Researchers
Prion Diseases
Biology & Genetics
Therapeutic Approaches
Animal Prion Diseases and Humans
Information for Researchers
Respiratory Syncytial Virus (RSV)
Prevention
Treatment
Schistosomiasis (Bilharzia)
Vaccines
Genomics
Treatment
Research in Endemic Regions
Sexually Transmitted Infections (STIs)
NIAID's Research Approach
Pathogens and Syndromes
Information for Researchers
Shigellosis
Biology & Genetics
Smallpox
Vaccine
Treatment
Tickborne Diseases
Disease-Specific Research
Information for Researchers
Tuberculosis
Basic Research
Vaccine Development
Diagnosis
Treatment
Information for Researchers
Vaccines
Types
Disease-Specific Vaccines
Vaccine Adjuvants
Reports & Strategic Plans
Information for Researchers
Vector Biology
Basic Research
Translational & Clinical Research
Vector-Host Interactions
Information for Researchers
West Nile Virus
Biology, Genetics & Clinical Research
Diagnosis
Treatment
Vaccines
Women's Health
NIAID's Approach to Women's Health Research
Scientific Advances
Sex-Specific Health Challenges Facing Women
Biennial Report (FY 2019-2020)
Information for Researchers
Zika Virus
Why NIAID Is Researching Zika Virus
Addressing Zika Virus
Basic Research
Vaccines
Diagnosis
Treatment
Information for Researchers
Grants & Contracts
Find a Funding Opportunity
Opportunities & Announcements
Types of Funding Opportunities
NIAID Research Priorities
See Funded Projects
Timelines & Due Dates
Apply for a Grant
Sample Applications
Determine Eligibility
Prepare Your Application
Plan Your Budget & Personnel
Additional Application Elements
Research with Special Considerations
Submit an Application
After You Submit an Application
Paylines & Funding
Track Your Application
Understand the Review Process
Respond to Pre-Award Requests
Manage Your Award
After Award
Negotiation & Initial Award
Contracts
Contract Solicitations
Rules & Policies
Contact the Office of Acquisitions
NIAID Funding News
Most Recent Edition
Browse by Edition Date
Search All Funding News
Clinical Trials
Find a Clinical Trial
Become a Healthy Volunteer
Participant's Guide to Clinical Trials
Participant Testimonials
HIV and Emerging Infectious Diseases
Partnership for Access to Clinical Trials (PACT)
Laboratory of Infectious Diseases
Primary Immune Deficiency Clinic
Vaccine Research Center Clinical Studies
Fill Out the Volunteer Form
Q&A: Vaccine Clinical Studies
Vaccine Clinical Studies Safeguards
Clinical Trial Publications
News & Events
Newsroom
News Releases
NIAID Now Blog
Media Inquiries
NIAID-Funded Research News
Events
Past Events
About NIAID
Organization
Office of the Director
Division of AIDS
Division of Allergy, Immunology, and Transplantation
Division of Microbiology and Infectious Diseases
Division of Extramural Activities
Division of Clinical Research
Division of Intramural Research
Vaccine Research Center
Organizational Chart
Find NIAID Staff
History
Dr. Joseph J. Kinyoun: Father of the NIH
Dr. Joseph Kinyoun The Indispensable Forgotten Man
Dr. Joseph Kinyoun: Selected Bibliography
NIAID 60th Anniversary Timeline
Budget & Planning
Evaluation at NIAID
Careers & Training
NIAID Careers
Research Training at NIAID Campuses
Grant Programs that NIAID Funds
Councils & Committees
AIDS Research Advisory Committee
AIDS Vaccine Research Subcommittee
Board of Scientific Counselors Members
Executive Committee
Advisory Council
Advisory and Peer Review Committees
Autoimmune Diseases Committee
Visitor Information
Mission
NIAID Mission
Website Policies and Notices
Accessibility on the Web
Comment Policy
Conflicts of Interest
Copyright and Reuse of Graphics and Text
External Link Icon and Disclaimers
Freedom of Information Act (FOIA)
No FEAR Act
NIAID Privacy Policy
PathogenAR Privacy Policy
Voluntarily Submitted Information
Website Help
Contact Us
Informaci贸n en espa帽ol
Temas de salud
NIAID Logo NIAID Logo
Group A Streptococcal Infections Menu

Group A Streptococcal Infections

Types of Group A Strep Biology & Genetics Vaccine Research Research Areas

Group A Streptococcal Infections

Group A streptococcal (GAS) infections can range from a mild skin infection or a sore throat to severe, life-threatening conditions VSports app下载. Most people are familiar with strep throat, which along with minor skin infections, is the most common form of the disease.

Why Is the Study of Group A Streptococcal Infections a Priority for NIAID? (V体育平台登录)

Health experts estimate that more than 10 million mild infections (throat and skin) occur every year.

V体育平台登录 - How Is NIAID Addressing This Critical Topic?

NIAID supports research to develop a group A streptococcus vaccine, and several candidate vaccines are in various phases of development. While some scientists are conducting animal model studies to obtain data to pursue clinical trials in humans, other scientists are close to evaluating group A streptococcus vaccine candidates in Phase I clinical trials VSports手机版.

As a result of NIAID-supported research, the first group A streptococcus vaccine clinical trial in 30 years was started V体育安卓版. The vaccine was well tolerated by patients and has led to further clinical evaluation of a similar vaccine candidate.

Funded Research News

See all Group A Streptococcal Infections funded research news

Related Public Health and Government Information

To learn about risk factors for GAS and current prevention and treatment strategies visit the MedlinePlus streptococcal infections site.

Content last reviewed on